Proceedings: Bioavailability and therapeutic efficacy.
作者信息
Withey R J
出版信息
Rev Can Biol. 1973;32:Suppl:21-30.
PMID:4777602
Abstract
摘要
相似文献
1
Proceedings: Bioavailability and therapeutic efficacy.论文集：生物利用度与治疗效果。
Rev Can Biol. 1973;32:Suppl:21-30.
2
Bioavailability, clinical effectiveness, and the public interest.
Pharmacology. 1972;8(1):33-43. doi: 10.1159/000136325.
3
[Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].[药理学与实用疗法。药物剂型选择原则及其来源方式]
Internist (Berl). 1973 Dec;14(12):661-7.
4
Proceedings: Mechanisms of drug absorption and of drug solution.
Rev Can Biol. 1973;32:Suppl:7-19.
5
Dose-dependent drug metabolism during the absorptive phase.
Rev Can Biol. 1973;32:Suppl:33-42.
6
Bioavailability of peroral dosage forms.口服剂型的生物利用度。
Boll Chim Farm. 1973 Mar;112(3):137-62.
7
[Influence of the starting materials on bioavailability of drugs].
Boll Chim Farm. 1973 Feb;112(2):83-93.
8
Proceedings: The line-up on bioavailability.会议记录：生物利用度的阵容。
Rev Can Biol. 1973;32:Suppl:151-5.
9
Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.药物的生物利用度：原理与问题。世界卫生组织科学小组报告
World Health Organ Tech Rep Ser. 1973 Nov;536:1-17.
10
Bioavailability of drugs (first of two parts).药物的生物利用度（两部分中的第一部分）。
N Engl J Med. 1974 Aug 1;291(5):233-7. doi: 10.1056/NEJM197408012910505.
引用本文的文献
1
Monitoring gold plasma levels in rheumatoid arthritis.监测类风湿关节炎患者的血浆金水平。
Clin Pharmacokinet. 1977 Mar-Apr;2(2):127-46. doi: 10.2165/00003088-197702020-00004.
Zotero 插件